Alex McAulay, a Senior Officer, acquired 2,086,800 Common Shares on an indirect ownership basis for registered holder ACM Management Inc. at a price of $0.158 through a private transaction on December 31st, 2021. This represents a $328,671 investment into the company's shares and an account share holdings change of greater than 100%.
CBD Global Sciences is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
CBD Global Sciences Inc. is a Canada-based cannabidiol (CBD) producer. The Company is engaged in the business of producing and selling industrial hemp derived CBD infused consumable and topical products, including but not limited to CBD oil tincture drops, CBD hydration beverages, and CBD topicals. It markets and sells its own brand of CBD oil and byproducts under the Aethics and CannaOil brands (Products), which includes CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, hydration products and confectionary products. Its hemp-derived CBD extracts are sold through distributors, brick and mortar retailers and online. The Company, through its wholly owned subsidiaries, Global Sciences Holdings, Resinosa LLC and Legacy Distribution Group, is delivering CBD products both in a retail and e-commerce formats. Its subsidiaries include Strasburg Pharms, LLC, Global NV Corp., CannaOil, Inc., SMBT, LLC, Global Sciences IP, LLC and Energy Unleased LLC, among others.
No Comments